In fact, high TMB increases the probability of generating neoantigens that can be recognized by tumor-infiltrating T cells, thereby enhancing the likelihood of a pre-existing antitumor immune response that can be unmasked by PD-1 blockade. The gene discussed is PDCD1; the disease is neoplasm.